Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis  Treated With Adalimumab, Etanercept, or Infliximab  Results From Eight Years of Surveillance of Clinical Practice in the Nationwide Danish DANBIO Registry

HETLAND Merete Lund; CHRISTENSEN Ib Jarle; TARP Ulrik; DREYER Lene; HANSEN Annette; HANSEN Ib Tonder; KOLLERUP Gina; LINDE Louise; LINDEGAARD Hanne M.; POULSEN Uta Engling; SCHLEMMER Annette; JENSEN Dorte Vendelbo; JENSEN Signe; HOSTENKAMP Gisela; OSTERGAARD Mikkel; HETLAND Merete Lund; LINDE Louise; HETLAND Merete Lund; LINDE Louise; CHRISTENSEN Ib Jarle; DREYER Lene; TARP Ulrik; SCHLEMMER Annette; HANSEN Annette; JENSEN Signe; OSTERGAARD Mikkel; HANSEN Ib Tonder; KOLLERUP Gina; LINDEGAARD Hanne M.; POULSEN Uta Engling; POULSEN Uta Engling; JENSEN Dorte Vendelbo; HOSTENKAMP Gisela

Art

J-GLOBAL ID：201102255021629292 Reference number：11A1220347

Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis Treated With Adalimumab, Etanercept, or Infliximab Results From Eight Years of Surveillance of Clinical Practice in the Nationwide Danish DANBIO Registry

アダリムマブ,エタネルセプト,インフリキシマブによる治療を受けた関節リウマチ患者における治療反応,寛解率,服薬遵守の直接比較:デンマーク全国DANBIO登録における8年間の臨床診療調査の結果

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=11A1220347&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1220347&from=J-GLOBAL&jstjournalNo=C0784B") }}

Author (33)： , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Material：
Volume： 62 Issue： 1 Page： 22-32 Publication year： Jan. 2010
JST Material Number： C0784B ISSN： 0004-3591 Document type： Article
Country of issue： United States (USA) Language： ENGLISH (EN)

, , , , , , , , , , , ,

Return to Previous Page